Literature DB >> 18390644

Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005.

Lene D Sjö1, Elisabeth Ralfkiaer, Jan U Prause, Jorgen H Petersen, Jakob Madsen, Niels T Pedersen, Steffen Heegaard.   

Abstract

PURPOSE: To evaluate patient characteristics and incidence of ophthalmic lymphoma in Denmark during the period 1980 to 2005.
METHODS: All patients in Denmark with a diagnosis of ophthalmic lymphoma during the period 1980 to 2005 were retrieved from three different population-based registries. Specimens from all patients were collected and reclassified according to the World Health Organization (WHO) classification system. Incidence rates were calculated by using Poisson regression models.
RESULTS: A total of 228 patients with a histologically verified diagnosis of ophthalmic lymphoma were included. There was an equal distribution of males and females. The most frequent lymphoma subtype was extranodal marginal zone B-cell lymphoma (MALT [mucosa-associated lymphoid tissue] lymphoma, 55.5%) and most cases were located in the orbit (56.8%). High-grade lymphoma subtypes were found more frequently in males than in females. Incidence rates were highly dependent on the patient's age. For all ages, a statistically significant annual average increase of 3.4% during the 26-year period was found. This increase was primarily due to a rise in the incidence of MALT lymphoma.
CONCLUSIONS: In the Danish population ophthalmic lymphoma consists primarily of orbital MALT lymphoma. Although it is a rare disease in mostly elderly patients, the incidence of ophthalmic lymphoma is increasing at a rapid pace.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18390644     DOI: 10.1167/iovs.08-1768

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  [Conjunctival malignancies].

Authors:  Claudia Auw-Hädrich; Thomas Reinhard
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

2.  MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2.

Authors:  Jiping Cai; Xiaoyu Liu; Jinwei Cheng; You Li; Xiao Huang; Yuzhen Li; Xiaoye Ma; Hongyu Yu; Huimin Liu; Ruili Wei
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-20       Impact factor: 3.117

3.  New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2008-09       Impact factor: 0.196

4.  Marginal zone mucosa associated lymphoid tissue diffuse large B cell lymphoma.

Authors:  Adrian Pedro Noriega Aldave; Shikha Jaiswal; Stephen L Davidson
Journal:  N Am J Med Sci       Date:  2014-08

5.  Clinico-epidemiological analysis of 1000 cases of orbital tumors.

Authors:  Hiroshi Goto; Naoyuki Yamakawa; Hiroyuki Komatsu; Masaki Asakage; Kinya Tsubota; Shun-Ichiro Ueda; Rei Nemoto; Kazuhiko Umazume; Yoshihiko Usui; Hideki Mori
Journal:  Jpn J Ophthalmol       Date:  2021-07-27       Impact factor: 2.447

6.  Ocular adnexal non-Hodgkin's lymphoma: a review of epidemiology and risk factors.

Authors:  Roxana Moslehi; Maria J Schymura; Seema Nayak; F Bruce Coles
Journal:  Expert Rev Ophthalmol       Date:  2011-04

7.  Orbital lymphoma: imaging features and differential diagnosis.

Authors:  Gema Priego; Carles Majos; Fina Climent; Amadeo Muntane
Journal:  Insights Imaging       Date:  2012-04-18

8.  Ocular surface tumors.

Authors:  Meghana Anika Varde; Jyotirmay Biswas
Journal:  Oman J Ophthalmol       Date:  2009-01

9.  Lacrimal gland lymphoma: Role of radiation therapy.

Authors:  Natasha Townsend; Aruna Turaka; Mitchell R Smith
Journal:  Oman J Ophthalmol       Date:  2012-01

Review 10.  Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy.

Authors:  Salvatore Perrone; Gianna Maria D'Elia; Giorgia Annechini; Alessandro Pulsoni
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-01-01       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.